This page shows the latest Braeburn Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... The first implant treatment for opioid dependence will be launched in the US shortly following FDA approval for Titan Pharma and Braeburn Pharma's Probuphine.
An FDA panel has backed approval of a long-acting buprenorphine implant for the management of opioid addiction developed by Titan Pharma and partner Braeburn Pharma. ... At the committee meeting, Braeburn presented summary safety findings with a
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...